We performed both free and albumin-bound bilirubin removal therapy using the Evaflux-2A and evaluated its clinical effects. The removal rates of total bilirubin in the first and second sessions were 31.4%, and 31.0%, respectively. Our clinical data suggested that plasma exchange using Evaflux-2A and an albumin-added electrolyte solution as the substitute fluid was useful in the treatment of hyperbilirubinemia.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
clinical trial
4
trial removal
4
removal bilirubin
4
bilirubin blood
4
blood evaflux-2a
4
evaflux-2a performed
4
performed free
4
free albumin-bound
4
albumin-bound bilirubin
4
bilirubin removal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!